EUROCELL PLC financials
EUROCELL PLC
213800RH62IQ7S9OFQ55 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £403.5M | £357.9M |
| Cost of sales | £198.2M | £169.6M |
| Gross profit | £205.3M | £188.3M |
| Distribution costs | £28.0M | £25.7M |
| Administrative expenses | £160.0M | £146.0M |
| Operating profit (EBIT) | £17.3M | £16.6M |
| Finance costs | £5.1M | £2.8M |
| Profit before tax | £12.2M | £13.8M |
| Income tax expense | £2.6M | £3.3M |
| Profit for the year | £9.6M | £10.5M |
| Total comprehensive income | £9.6M | £10.5M |
| Cash flow statement | ||
| Cash generated from operations | £50.1M | £47.2M |
| Net cash from operating activities | £48.4M | £44.2M |
| Net cash from investing activities | -£33.1M | -£10.3M |
| Purchase of PP&E (capex) | £12.3M | £10.2M |
| Purchase of intangibles | £200.0K | £100.0K |
| Net cash from financing activities | -£6.4M | -£36.9M |
| Dividends paid | £6.2M | £6.1M |
| Proceeds from borrowings | £27.0M | £1.0M |
| Balance sheet | ||
| Total assets | £287.8M | £223.8M |
| Non-current assets | £175.6M | £129.4M |
| Property, plant & equipment | £63.2M | £60.5M |
| Right-of-use assets | £71.6M | £54.3M |
| Intangible assets & goodwill | £36.1M | £10.8M |
| Current assets | £112.2M | £94.4M |
| Inventories | £53.6M | £47.2M |
| Trade & other receivables | £51.9M | £45.8M |
| Cash & equivalents | £6.3M | £400.0K |
| Total equity | £104.8M | £105.4M |
| Non-current liabilities | £109.8M | £57.3M |
| Long-term borrowings | £27.7M | £500.0K |
| Lease liabilities (non-current) | £61.7M | £46.9M |
| Current liabilities | £73.2M | £61.1M |
| Lease liabilities (current) | £14.4M | £12.5M |
| Trade & other payables | £54.0M | £45.2M |
| Deferred tax liabilities | £10.0M | £8.6M |
| Derived metrics | ||
| Free cash flow | £36.1M | £34.0M |
| Operating margin | 4.3% | 4.6% |
| Net margin | 2.4% | 2.9% |
| Return on equity | 9.2% | 10.0% |
| Cash conversion ratio | 5.04× | 4.21× |
| Capex coverage | 3.94× | 4.33× |
| Other reported items | ||
| Basic Earnings Loss Per Share From Continuing Operations | £0.10 | £0.10 |
| Cancellation of Treasury Shares | £0 | £0 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | £6.3M | -£2.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £20.6M | £0 |
| Current Provisions | £500.0K | £400.0K |
| Current Tax Assets | £400.0K | £1.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | £0.09 | £0.10 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £0.04 | £0.04 |
| Income Taxes Paid Refund Classified As Operating Activities | £1.7M | £3.0M |
| Increase Decrease In Cash and Cash Equivalents | £8.9M | -£3.0M |
| Increase Decrease Through Acquisition of Subsidiary | £1.1M | — |
| Increase Decrease Through Exercise of Options | -£100.0K | -£300.0K |
| Increase Decrease Through Sharebased Payment Transactions | £1.0M | £1.5M |
| Increase Decrease Through Transactions With Owners | -£10.2M | -£19.4M |
| Intangible Assets Other Than Goodwill | £4.7M | £3.8M |
| Issued Capital | £100.0K | £100.0K |
| Liabilities | £183.0M | £118.4M |
| Liabilities Due To Central Banks | £0 | £3.0M |
| Net Assets Liabilities | £104.8M | £105.4M |
| Noncurrent Provisions | £1.8M | £1.3M |
| Payments To Acquire Or Redeem Entitys Shares | £1.0M | £1.9M |
| Proceeds From Exercise of Options | £0 | -£100.0K |
| Purchase of Treasury Shares | £6.0M | £14.5M |
| Reserve of Sharebased Payments | £2.4M | £2.3M |
| Retained Earnings | £81.0M | £82.8M |
| Share Premium | £22.2M | £22.2M |
| Treasury Shares | £900.0K | £2.0M |
Every line item above is a fact tagged in EUROCELL PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.